Santhera Pharmaceuticals Holding AG (LON:0QN1)
London
· Delayed Price · Currency is GBP · Price in CHF 14.56
-0.04 (-0.27%)
Apr 24, 2025, 1:47 PM BST
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 45 employees as of December 31, 2023. The number of employees decreased by 1 or -2.18% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.18%
Revenue / Employee
2.22M GBP
Profits / Employee
1.23M GBP
Market Cap
164.03M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,315 |
Santhera Pharmaceuticals Holding AG News
- 7 weeks ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 3 months ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 3 months ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 4 months ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 8 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire